Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data – (Eye Journal)
Eye, Published online: 16 December 2019; doi:10.1038/s41433-019-0745-z Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data
Fibrosis in dysthyroid eye disease – (Eye Journal)
Eye, Published online: 16 December 2019; doi:10.1038/s41433-019-0731-5 Fibrosis in dysthyroid eye disease
Response to ‘Comment on: ‘You have got dry macular degeneration, end of story’: a qualitative study into the experience of living with non-neovascular age-related macular degeneration’ – (Eye Journal)
Eye, Published online: 13 December 2019; doi:10.1038/s41433-019-0732-4 Response to ‘Comment on: ‘You have got dry macular degeneration, end of story’: a qualitative study into the experience of living with non-neovascular age-related macular degeneration’
A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom – (Eye Journal)
Eye, Published online: 13 December 2019; doi:10.1038/s41433-019-0664-z A survey of current practices by the British Oculoplastic Surgery Society (BOPSS) and recommendations for delivering a sustainable multidisciplinary approach to thyroid eye disease in the United Kingdom
Comment on: ‘You’ve got dry macular degeneration, end of story: a qualitative study into the experience of living with non-neovascular age-related macular degeneration’ – (Eye Journal)
Eye, Published online: 13 December 2019; doi:10.1038/s41433-019-0730-6 Comment on: ‘You’ve got dry macular degeneration, end of story: a qualitative study into the experience of living with non-neovascular age-related macular degeneration’